The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti–vascular Endothelial Growth Factor Therapy Market Research Report 2025

Global Anti–vascular Endothelial Growth Factor Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1987409

No of Pages : 69

Ask Your Query
Synopsis
Anti–vascular Endothelial Growth Factor Therapy is a medical treatment used primarily in ophthalmology to address conditions like age-related macular degeneration and diabetic retinopathy. It involves the use of drugs that inhibit VEGF, a protein responsible for promoting abnormal blood vessel growth. By reducing VEGF activity, the therapy aims to slow down the progression of these eye diseases and prevent vision loss.
The global Anti–vascular Endothelial Growth Factor Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti–vascular Endothelial Growth Factor Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti–vascular Endothelial Growth Factor Therapy.
Report Scope
The Anti–vascular Endothelial Growth Factor Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti–vascular Endothelial Growth Factor Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti–vascular Endothelial Growth Factor Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
Segment by Type
Extraction Injection
Precharge Injection
Segment by Application
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti–vascular Endothelial Growth Factor Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Extraction Injection
1.2.3 Precharge Injection
1.3 Market by Application
1.3.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Macular Degeneration
1.3.3 Nacular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Perspective (2019-2030)
2.2 Anti–vascular Endothelial Growth Factor Therapy Growth Trends by Region
2.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Region (2019-2024)
2.2.3 Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2025-2030)
2.3 Anti–vascular Endothelial Growth Factor Therapy Market Dynamics
2.3.1 Anti–vascular Endothelial Growth Factor Therapy Industry Trends
2.3.2 Anti–vascular Endothelial Growth Factor Therapy Market Drivers
2.3.3 Anti–vascular Endothelial Growth Factor Therapy Market Challenges
2.3.4 Anti–vascular Endothelial Growth Factor Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue
3.1.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue (2019-2024)
3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti–vascular Endothelial Growth Factor Therapy Revenue
3.4 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio
3.4.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2023
3.5 Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Area Served
3.6 Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
3.7 Date of Enter into Anti–vascular Endothelial Growth Factor Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Type
4.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Type (2019-2024)
4.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2025-2030)
5 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Application
5.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Application (2019-2024)
5.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size (2019-2030)
6.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024)
6.4 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size (2019-2030)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024)
7.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size (2019-2030)
8.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size (2019-2030)
9.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024)
9.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size (2019-2030)
10.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Company Detail
11.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Introduction
11.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
11.2 Genentech
11.2.1 Genentech Company Detail
11.2.2 Genentech Business Overview
11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Introduction
11.2.4 Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
11.2.5 Genentech Recent Development
11.3 Kanghong Pharmaceutical
11.3.1 Kanghong Pharmaceutical Company Detail
11.3.2 Kanghong Pharmaceutical Business Overview
11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Introduction
11.3.4 Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
11.3.5 Kanghong Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Extraction Injection
Table 3. Key Players of Precharge Injection
Table 4. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2019-2024)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2025-2030)
Table 10. Anti–vascular Endothelial Growth Factor Therapy Market Trends
Table 11. Anti–vascular Endothelial Growth Factor Therapy Market Drivers
Table 12. Anti–vascular Endothelial Growth Factor Therapy Market Challenges
Table 13. Anti–vascular Endothelial Growth Factor Therapy Market Restraints
Table 14. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players (2019-2024)
Table 16. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2023)
Table 17. Ranking of Global Top Anti–vascular Endothelial Growth Factor Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
Table 21. Date of Enter into Anti–vascular Endothelial Growth Factor Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Regeneron Pharmaceuticals (Eylea) Company Detail
Table 47. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 48. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product
Table 49. Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024) & (US$ Million)
Table 50. Regeneron Pharmaceuticals (Eylea) Recent Development
Table 51. Genentech Company Detail
Table 52. Genentech Business Overview
Table 53. Genentech Anti–vascular Endothelial Growth Factor Therapy Product
Table 54. Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024) & (US$ Million)
Table 55. Genentech Recent Development
Table 56. Kanghong Pharmaceutical Company Detail
Table 57. Kanghong Pharmaceutical Business Overview
Table 58. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product
Table 59. Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024) & (US$ Million)
Table 60. Kanghong Pharmaceutical Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Type: 2023 VS 2030
Figure 3. Extraction Injection Features
Figure 4. Precharge Injection Features
Figure 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2023 VS 2030
Figure 7. Macular Degeneration Case Studies
Figure 8. Nacular Edema Case Studies
Figure 9. Uveitis Case Studies
Figure 10. Retinal Vein Occlusion Case Studies
Figure 11. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 12. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Anti–vascular Endothelial Growth Factor Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players in 2023
Figure 16. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2023
Figure 18. North America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2019-2030)
Figure 20. United States Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2019-2030)
Figure 24. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2019-2030)
Figure 32. China Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2019-2030)
Figure 40. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2019-2030)
Figure 44. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
Figure 47. Genentech Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
Figure 48. Kanghong Pharmaceutical Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock